Showing results (3611-3620 of 5,706) with videos related to
Sort By:
Pageof 571
BMC Neurology|September 28, 2005
Visual recovery after perinatal stroke evidenced by functional and diffusion MRI: case reportMohamed L Seghier, François Lazeyras, Slava Zimine, et al.BMC Neurology|January 31, 2007
Intravenous immune globulin in hereditary inclusion body myopathy: a pilot studySusan Sparks, Goran Rakocevic, Galen Joe, et al.BMC Neurology|March 21, 2007
Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complicationsJan Vesper, Susanne Haak, Christoph Ostertag, et al.BMC Neurology|December 13, 2006
Abnormal susceptibility to distracters hinders perception in early stage Parkinson's disease: a controlled studyJan Berend Deijen, Diederick Stoffers, Henk W Berendse, et al.BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.BMC Neurology|July 20, 2007
Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trialKatherine A Grosset, Donald G GrossetBMC Neurology|May 18, 2007
Latent profile analysis in frontotemporal lobar degeneration and related disorders: clinical presentation and SPECT functional correlatesBarbara Borroni, Mario Grassi, Chiara Agosti, et al.BMC Neurology|June 28, 2006
Deviation of eyes and head in acute cerebral strokeM Fruhmann Berger, R D Pross, U J Ilg, et al.BMC Neurology|August 25, 2006
Leg orientation as a clinical sign for pusher syndromeLeif Johannsen, Doris Broetz, Hans-Otto KarnathBMC Neurology|May 20, 2006
Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosisJun-ichi Satoh, Yusuke Nanri, Hiroko Tabunoki, et al.Pageof 571